Components:
Treatment option:
Medically reviewed by Fedorchenko Olga Valeryevna, PharmD. Last updated on 12.03.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Clotrimazole Vaginal Cream will cure most vaginal yeast (candida) infections.
Clotrimazole Vaginal Cream can kill the yeast that cause vaginal yeast infections and can relieve the associated itching and burning.
Directions
Fill the applicator with the cream and then insert one applicatorful of cream into the vagina every day, preferably at bedtime. Dispose of applicator after use.
Repeat this procedure with a new applicator for 7 consecutive days. For relief of external vulvar itching, squeeze a small amount of cream onto your finger and gently spread the cream onto the irritated area of the vulva. Use once or twice a day for up to 7 days as needed to relieve external vulvar itching.
THE CREAM SHOULD NOT BE USED FOR VULVAR ITCHING DUE TO CAUSES OTHER THAN A YEAST INFECTION.
Important: In order to kill the yeast completely, you must use CLOTRIMAZOLE VAGINAL CREAM the full seven days, as instructed above, even if your symptoms are relieved sooner.
WARNINGS
†Do not use if you have abdominal pain, fever, or a foul-smelling vaginal discharge. You may have a condition which is more serious than a yeast infection. Contact your doctor immediately.
†Do not use if this is your first experience with vaginal itch and discomfort. See your doctor.
†If there is no improvement within 3 days, you may have a condition other than a yeast infection. Stop using this product and see your doctor.
†If you may have been exposed to the human immunodeficiency virus (HIV, the virus that causes AIDS) and are now having recurrent vaginal yeast infections, especially infections that don†t clear up easily with proper treatment, see your doctor promptly to determine the cause of your symptoms and to receive proper medical care.
†If symptoms recur within a 2 month period, contact your doctor.
†Do not use during pregnancy except under the advice and supervision of a doctor.
†This medication is for use in the vaginal and vulvar areas only. It is not for use in the mouth or the eyes. In case accidentally swallowed, seek professional assistance or contact a Poison Control Center immediately.
† Keep this and all drugs out of reach of children. This product is not to be used in children less than 12 years of age.
If you have questions about Clotrimazole Vaginal Cream or vaginal yeast infections, contact your doctor.
PRECAUTIONS
No information provided.
See PATIENT INFORMATION section.
No information provided.
No information provided.
Transcriptional profiling analysis of Penicillium digitatum, the causal agent of citrus green mold, unravels an inhibited ergosterol biosynthesis pathway in response to citral
Targeting efflux pumps to overcome antifungal drug resistance
Evaluation of the proximate composition, antioxidant potential, and antimicrobial activity of mango seed kernel extracts
Mutations of charged amino acids at the cytoplasmic end of transmembrane helix 2 affect transport activity of the budding yeast multidrug resistance protein Pdr5p
Clotrimazole Drug Resistance in Candida glabrata Clinical Isolates Correlates with Increased Expression of the Drug:H+ Antiporters CgAqr1, CgTpo1_1, CgTpo3, and CgQdr2
A New Endogenous Overexpression System of Multidrug Transporters of Candida albicans Suitable for Structural and Functional Studies
Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer
First description of Candida nivariensis in Brazil:antifungal susceptibility profile and potential virulence attributes
The Y137H mutation of VvCYP51 gene confers the reduced sensitivity to tebuconazole in Villosiclava virens
Membrane Proteome-Wide Response to the Antifungal Drug Clotrimazole in Candida glabrata: Role of the Transcription Factor CgPdr1 and the Drug:H+ Antiporters CgTpo1_1 and CgTpo1_2*
Changes in the Sterol Composition of the Plasma Membrane Affect Membrane Potential, Salt Tolerance and the Activity of Multidrug Resistance Pumps in Saccharomyces cerevisiae
Mutational Analysis of Intracellular Loops Identify Cross Talk with Nucleotide Binding Domains of Yeast ABC Transporter Cdr1p
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans
From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms
Azole Drug Import into the Pathogenic Fungus Aspergillus fumigatus
The multidrug transporter Pdr5 on the 25th anniversary of its discovery: an important model for the study of asymmetric ABC transporters
The Use of the LanthaScreen TR-FRET CAR Coactivator Assay in the Characterization of Constitutive Androstane Receptor (CAR) Inverse Agonists
Synthesis, Bioactivity, Molecular Docking and POM Analyses of Novel Substituted Thieno[2,3-b]thiophenes and Related Congeners
Blood Brain Barrier KCa3.1 Channels: Evidence for a Role in Brain Na Uptake and Edema in Ischemic Stroke
Drug StrategiesTargeting CYP51 in Neglected TropicalDiseases
